Key facts
- It has raised $1.4M; the latest was Seed Round ($1.4M) in Jul 2025.
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Jiaze Medical Technology
- ·The full record, as it builds
Funding rounds
No funding rounds for Jiaze Medical Technology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Jiaze Medical Technology
Manufacturer of pet-medical drugs intended to address drug shortages, staffing gaps, and operational challenges in the pet-care sector. The company offers integrated drug R&D, smart medical devices, chain branding, and talent training, enabling pet clinics and veterinary networks to expand their service reach and enhance care quality.
- Sector
- Healthcare
- HQ
- Changchun, China
- Founded
- 2025
- Ownership
- Privately Held (backing)
Jiaze Medical Technology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Jiaze Medical Technology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Jiaze Medical Technology in its N-PORT filings yet. We sweep new filings monthly.